Washed Microbiota Transplantation for Patients With 2019-nCoV Infection
NCT04251767 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2020-03-17
Summary
Gut dysbiosis co-exists in patients with coronavirus pneumonia. Some of these patients would develop secondary bacterial infections and antibiotic-associated diarrhea (AAD). The recent study on using washed microbiota transplantation (WMT) as rescue therapy in critically ill patients with AAD demonstrated the important clinical benefits and safety of WMT. This clinical trial aims to evaluate the outcome of WMT combining with standard therapy for patients with 2019-novel coronavirus pneumonia, especially for those patients with dysbiosis-related conditions.
Conditions
- COVID-19 Complicated With Refractory Intestinal Infections
Interventions
- OTHER
-
washed microbiota transplantation
Washed microbiota suspension (5u) delivered through nasogastric tube, nasojejunal tube or oral. Dose and frequency: 5u, once.
- OTHER
-
placebo
Placebo (edible suspension of the same color as the washed microbiota suspension,5u) administered via nasogastric tube, nasojejunal tube or oral, combining with standard therapy. Dose and frequency: 5u, once.
Sponsors & Collaborators
-
The Second Hospital of Nanjing Medical University
lead OTHER
Principal Investigators
-
Faming Zhang, MD; PHD · The Second Hospital of Nanjing Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-05
- Primary Completion
- 2020-04-30
- Completion
- 2020-04-30
Countries
- China
Study Locations
More Related Trials
-
Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea
NCT05990972 ·Status: COMPLETED ·Phase: NA
-
FMT for MDRO Colonization in Solid Organ Transplant
NCT02816437 ·Status: WITHDRAWN ·Phase: PHASE1
-
FMT for Lung and Associated-organ Rescue Efficacy in MDRO-infected Ventilated Patients
NCT06970262 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Explore Efficacy of FMT Treating Childhood ASD Patients
NCT04142255 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms
NCT07265817 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics
NCT03862079 ·Status: WITHDRAWN ·Phase: PHASE2
-
Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization
NCT03061097 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus
NCT05253768 ·Status: RECRUITING ·Phase: PHASE2
-
Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum
NCT02343328 ·Status: TERMINATED ·Phase: PHASE1
-
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
NCT07261826 ·Status: RECRUITING
-
The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection
NCT05703477 ·Status: COMPLETED ·Phase: NA
-
Stool Transplant to Control Treatment-related Diarrhea
NCT04883762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization
NCT04746222 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae
NCT04146337 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease
NCT03998423 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers
NCT05742074 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization
NCT03391674 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)
NCT02782325 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress
NCT04443075 ·Status: COMPLETED
-
Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection
NCT03973697 ·Status: TERMINATED ·Phase: PHASE2
-
Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)
NCT03970200 ·Status: TERMINATED ·Phase: PHASE2
-
MTT for Children With ASD Who Have Gastrointestinal Disorders
NCT04182633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Application of Fecal Microbiota Transplantation in Children With ASD
NCT04948814 ·Status: UNKNOWN ·Phase: PHASE1
-
Fecal Transplant for MDR Pathogen Decolonization
NCT02906774 ·Status: TERMINATED
-
PMT for MDRO Decolonization
NCT05632315 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2